{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:08:29Z","timestamp":1779368909913,"version":"3.53.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Agence de la Biomedecine"},{"name":"National Research Agency"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Lupus activity has long been considered to decline after initiation of maintenance dialysis (MD). This assumption is based on limited historical data. We aimed to describe the natural history of lupus in patients undergoing MD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We assembled a national retrospective cohort of lupus patients who started dialysis between 2008 and 2011, included in the REIN registry with a 5-year follow-up. We analysed healthcare consumption from the National Health Data System. We evaluated the proportion of patients \u2018off-treatment\u2019 (i.e. receiving 0\u20135\u2009mg\/d of corticosteroids, without any immunosuppressive therapy) after the start of MD. We describe the cumulative incidences of non-severe and severe lupus flares, cardiovascular events, severe infections, kidney transplantation and survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 137 patients (121 females and 16 males), with a median age of 42\u2009years. The proportion of patients \u2018off-treatment\u2019 at dialysis initiation was 67.7% (95% CI: 61.8, 73.8%), and increased to 76.0% (95% CI: 73.3, 78.8) at 1\u2009year and 83.4% (95% CI: 81.0, 85.9%) at 3\u2009years, with a lower proportion in younger patients. Lupus flares mainly occurred in the first year after MD initiation, and at 12\u2009months 51.6% of patients had presented a non-severe lupus flare and 11.6% a severe lupus flare. In addition, 42.2% (95% CI: 32.9, 50.3%) and 23.7% (95% CI: 16.0, 30.7%) of patients at 12\u2009months had been hospitalized for cardiovascular events or infections, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The proportion of lupus patients off-treatment increases after MD initiation, but non-severe and severe lupus flares continue to occur, mainly during the first year. This calls for the continued follow-up of lupus patients by lupus specialists after dialysis initiation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead293","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T15:14:19Z","timestamp":1687274059000},"page":"780-786","source":"Crossref","is-referenced-by-count":4,"title":["Lupus activity and outcomes in lupus patients undergoing maintenance dialysis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7248-8418","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Gaillard","sequence":"first","affiliation":[{"name":"Service de Transplantation, N\u00e9phrologie et Immunologie Clinique, H\u00f4pital Edouard Herriot , Lyon, France"},{"name":"Research on Healthcare Performance RESHAPE, INSERM U1290, Universit\u00e9 Claude Bernard Lyon 1 , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bachelet","sequence":"additional","affiliation":[{"name":"Department of Biostatistical Epidemiology and Clinical Research, H\u00f4pital Bichat, Assistance Publique-H\u00f4pitaux de Paris, INSERM CIC-EC 1425 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Couchoud","sequence":"additional","affiliation":[{"name":"REIN, Agence de la Biom\u00e9decine, Saint Denis la Plaine , Saint Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Laouenan","sequence":"additional","affiliation":[{"name":"Department of Biostatistical Epidemiology and Clinical Research, H\u00f4pital Bichat, Assistance Publique-H\u00f4pitaux de Paris, INSERM CIC-EC 1425 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katell","family":"Peoc\u2019h","sequence":"additional","affiliation":[{"name":"Laboratoire d'Excellence GR-Ex, Universit\u00e9 Paris Cit\u00e9, Centre de Recherche sur l\u2019Inflammation, INSERM UMR1149 , Paris, France"},{"name":"Service de Biochimie, H\u00f4pital Bichat, DMU BIOGEM, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Simon","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Excellence Inflamex, Universit\u00e9 Paris Cit\u00e9; Centre de Recherche sur l\u2019inflammation, INSERM UMR1149, CNRS EL8252 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Charles","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Excellence Inflamex, Universit\u00e9 Paris Cit\u00e9; Centre de Recherche sur l\u2019inflammation, INSERM UMR1149, CNRS EL8252 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-1577","authenticated-orcid":false,"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[{"name":"Aix-Marseille Univ, C2VN, INSERM, INRAE , Marseille, France"},{"name":"AP-HM, Centre de N\u00e9phrologie et Transplantation R\u00e9nale, H\u00f4pital de la Conception , Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Daugas","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Excellence Inflamex, Universit\u00e9 Paris Cit\u00e9; Centre de Recherche sur l\u2019inflammation, INSERM UMR1149, CNRS EL8252 , Paris, France"},{"name":"Department of Nephrology, H\u00f4pital Bichat, Assistance Publique-H\u00f4pitaux de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2024030205492801900_kead293-B1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.autrev.2014.08.034","article-title":"Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2024030205492801900_kead293-B2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/art.38006","article-title":"Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus: SMR and life expectancy of patients with lupus renal disease","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2024030205492801900_kead293-B3","first-page":"2503"},{"key":"2024030205492801900_kead293-B4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2019.05.011","article-title":"The burden of chronic kidney disease in systemic lupus erythematosus: a nationwide epidemiologic study","volume":"18","author":"Mageau","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2024030205492801900_kead293-B5","author":"Agence de la Biom\u00e9decine","year":"2017"},{"key":"2024030205492801900_kead293-B6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/0961203315578763","article-title":"Outcome of patients with systemic lupus erythematosus on chronic dialysis: an observational study of incident patients of the French National Registry 2002\u20132012","volume":"24","author":"Levy","year":"2015","journal-title":"Lupus"},{"key":"2024030205492801900_kead293-B7","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2215\/CJN.03680411","article-title":"Early outcomes among those initiating chronic dialysis in the United States","volume":"6","author":"Chan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024030205492801900_kead293-B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3349\/ymj.2004.45.2.199","article-title":"The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis","volume":"45","author":"Goo","year":"2004","journal-title":"Yonsei Med J"},{"key":"2024030205492801900_kead293-B9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1191\/0961203303lu474oa","article-title":"Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients","volume":"12","author":"Lee","year":"2003","journal-title":"Lupus"},{"key":"2024030205492801900_kead293-B10","first-page":"1520","article-title":"Factors associated with active systemic lupus erythematosus after endstage renal disease","volume":"25","author":"Szeto","year":"1998","journal-title":"J Rheumatol"},{"key":"2024030205492801900_kead293-B11","first-page":"456","article-title":"Clinicopathological study of dialysis patients with lupus nephritis","volume":"37","author":"Kobayashi","year":"1995","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"2024030205492801900_kead293-B12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81017-1","article-title":"Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity","volume":"16","author":"Cheigh","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"2024030205492801900_kead293-B13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(90)90295-O","article-title":"Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE","volume":"89","author":"Nossent","year":"1990","journal-title":"Am J Med"},{"key":"2024030205492801900_kead293-B14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9343(87)90888-6","article-title":"Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis","volume":"83","author":"Rodby","year":"1987","journal-title":"Am J Med"},{"key":"2024030205492801900_kead293-B15","first-page":"293","article-title":"End-stage renal failure in systemic lupus erythematosus with nephritis","volume":"22","author":"Correia","year":"1984","journal-title":"Clin Nephrol"},{"key":"2024030205492801900_kead293-B16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1525-1594.1984.tb04318.x","article-title":"Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities","volume":"8","author":"Pahl","year":"1984","journal-title":"Artif Organs"},{"key":"2024030205492801900_kead293-B17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archinte.1983.00350070073014","article-title":"The clinical course of end-stage renal disease in systemic lupus erythematosus","volume":"143","author":"Jarrett","year":"1983","journal-title":"Arch Intern Med"},{"key":"2024030205492801900_kead293-B18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM198301273080403","article-title":"The long-term clinical course of systemic lupus erythematosus in end-stage renal disease","volume":"308","author":"Coplon","year":"1983","journal-title":"N Engl J Med"},{"key":"2024030205492801900_kead293-B19","first-page":"166","article-title":"Late-stage lupus nephropathy","volume":"1","author":"Fries","year":"1974","journal-title":"J Rheumatol"},{"key":"2024030205492801900_kead293-B20","first-page":"884","article-title":"Regression of clinical and immunological expression of systemic lupus-erythematosus (SLE) consequent to development of uremia","author":"Brown","year":"1979"},{"key":"2024030205492801900_kead293-B21","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65(Suppl 4)","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2024030205492801900_kead293-B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-020-1692-4","article-title":"Linking disease registries and nationwide healthcare administrative databases: the French renal epidemiology and information network (REIN) insight","volume":"21","author":"Raffray","year":"2020","journal-title":"BMC Nephrol"},{"key":"2024030205492801900_kead293-B23"},{"key":"2024030205492801900_kead293-B24","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology"},{"key":"2024030205492801900_kead293-B25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024030205492801900_kead293-B26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1159\/000089708","article-title":"Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort","volume":"25","author":"Ribeiro","year":"2005","journal-title":"Am J Nephrol"},{"key":"2024030205492801900_kead293-B27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3904\/kjim.2011.26.1.60","article-title":"Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis","volume":"26","author":"Kang","year":"2011","journal-title":"Korean J Intern Med"},{"key":"2024030205492801900_kead293-B28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2215\/CJN.02500314","article-title":"Comparison of mortality of ESRD patients with lupus by initial dialysis modality","volume":"9","author":"Contreras","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024030205492801900_kead293-B29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology"},{"key":"2024030205492801900_kead293-B30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3899\/jrheum.220101","article-title":"Disease flare of systemic lupus erythematosus in patients with endstage renal disease on dialysis","volume":"49","author":"Kim","year":"2022","journal-title":"J Rheumatol"},{"key":"2024030205492801900_kead293-B31","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/jcm11133587","article-title":"Long-term clinical outcome in systemic lupus erythematosus patients followed for more than 20 years: the Milan systemic lupus erythematosus consortium (SMiLE) cohort","volume":"11","author":"Gerosa","year":"2022","journal-title":"J Clin Med"},{"key":"2024030205492801900_kead293-B32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2021.07.013","article-title":"Dialysis outcomes for children with lupus nephritis compared to children with other forms of nephritis: a retrospective cohort study","volume":"79","author":"Wasik","year":"2022","journal-title":"Am J Kidney Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead293\/50840522\/kead293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/780\/56818697\/kead293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/780\/56818697\/kead293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T05:50:07Z","timestamp":1709358607000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/3\/780\/7203795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6,20]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead293","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,6,20]]}}}